Manufacturing

This is annual forum that focuses on novel predictive methods and technologies for the rational development and production of next-generation biological drug products. This 2013 program embraces regulatory aspects of such issues as aggregation and immunogenicity to utilizing biosimilars in therapeutic and biologic development.

IBC's Antibody Engineering & Therapeutics meeting has earned its reputation by consistently offering the most current academic research findings and most recent industry updates. Our attendees come back year after year for the information they need to find new approaches to developing novel medicines and vaccines and to improve the safety and efficacy of antibody therapeutics now in development.

IBC's Flexible Facilities conference is designed to bring together thought leaders from biologics drug developers, engineering firms, CMOs, technology providers and governmental bodies to share best practices and new ideas.